Jeffrey K Duncan-Lowey

5PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Ship and platform structures (incl. maritime hydrodynamics)Molecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 25, 2025
A diverse family of bacterial deubiquitinases is defined by the Coxiella burnetii effector EmcB.

Jeffrey K Duncan-Lowey, Craig R Roy

|Mar 09, 2023
The Coxiella burnetii effector EmcB is a deubiquitinase that inhibits RIG-I signaling.

Jeffrey Duncan-Lowey, Emerson Crabill, Abigail Jarret

|Sep 09, 2021
The type 3 secretion system requires actin polymerization to open translocon pores.

Brian C Russo, Jeffrey K Duncan-Lowey, Poyin Chen

|Aug 11, 2021
Coronavirus Disease 2019 in a Patient With a Systemic Autoinflammatory Syndrome due to an NLRC4 Inflammasomopathy.

Jeffrey K Duncan-Lowey, Vaidehi Chowdhary, Dana W Dunne

|Nov 15, 2019
Activation of Shigella flexneri type 3 secretion requires a host-induced conformational change to the translocon pore.

Brian C Russo, Jeffrey K Duncan, Alexandra L Wiscovitch

Pageof 1

Frequent Collaborators

2 joint publications

Marcia B Goldberg

1 joint publications

Emerson Crabill

1 joint publications

Shawna C O Reed

1 joint publications

Vaidehi Chowdhary